Humana Inc. Stock Rallies 4.6%, Outperforms Peers
Dow Jones2026/09/25 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Humana Inc. advanced 4.6% to $397.93 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.5% to 7,743.41 and the Dow Jones Industrial Average rising 0.9% to 51,828.62.
This was the stock's third consecutive day of gains.
Humana Inc. closed 7.2% short of its 52-week high of $428.88, which the company reached on July 16th.
The stock outperformed some of its peers, as UnitedHealth Group Inc. rose 0.4% to $376.59, Elevance Health Inc. fell 0.5% to $396.09, and Chubb Ltd. fell 0.44% to $333.37.
Trading volume totaled 1.9 million, compared to the 50-day average of 1.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 25, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks
Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.
Crypto prices
More
